Drugs · acquisition-cost intelligence
Amerithroid
LEVOTHYROXINE and LIOTHYRONINE· ingredient thyroid (USP)· LEVOTHYROXINE 114 ug/1; LIOTHYRONINE 27 ug/1; LEVOTHYROXINE 19 ug/1; LIOTHYRONINE 4.5 ug/1; LEVOTHYROXINE 28.5 ug/1; LIOTHYRONINE 6.75 ug/1; LEVOTHYROXINE 38 ug/1; LIOTHYRONINE 9 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$1.06
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other thyroid (USP) products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| NP Thyroid | $0.66500 | −$0.39230 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.